arrow_back Back to App

Mandating Presidential Disclosure of Drugs Affecting Cognitive Function to Congress.

This bill introduces a new requirement for the President of the United States, aiming to increase transparency regarding their fitness for office. The President must notify Congress whenever they ingest specific substances that affect alertness, judgment, or mood. This measure potentially gives citizens greater insight into the health and mental condition of the nation's highest official.
Key points
The President must report to Congress (House and Senate) the use of stimulants (excluding caffeine/nicotine), anabolic steroids, narcotics, or other substances that alter cognitive function.
This disclosure must occur within five days of taking the substance.
The goal is to ensure Congress is informed about any medication that could impact the President's decision-making ability.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_8736
Sponsor: Rep. Ogles, Andrew [R-TN-5]
Process start date: 2024-06-13